Santhera Announces AGAMREE® Reimbursement Agreement in Germany
Ad hoc announcement pursuant to Art. 53 LR Santhera Pharmaceuticals (SIX: SANN), a specialty pharmaceutical company focused on rare diseases, today announces an agreement with...
Category : Healthcare and Pharmaceutical
Cytovation Appoints Martin Dewhurst to its Board of Directors
Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces the appointment of Mr. Martin Dewhurst to...
Gilde Healthcare sells health-IT company Performation to Enovation
Gilde Healthcare announces successful sale of health-IT software company Performation to Enovation, part of Legrand Gilde Healthcare, the specialized healthcare investor, today announces the sale...
PulseSight Announces Series A Close to Fund PST-611 in AMD
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its Series A...
AdvancedMD Unveils 20+ Updates, Including Enhanced Patient Cards
The redesigned Patient and Responsible Party Card framework offers an improved, more comprehensive user experience that streamlines workflow processes AdvancedMD, a provider of cloud-based healthcare...
Harrison.ai Expands to US with $112M Series C for AI Healthtech
Company’s Radiology and Pathology Solutions Expand Clinician Capacity, Increase Operational Efficiency, and Improve Early Disease Diagnosis Harrison.ai, a leading global healthtech company and developer of...
Symphony Robotics Licenses New Tech to Combat Brain Tumors
Symphony Robotics has secured an exclusive worldwide license from Case Western Reserve University (CWRU) for a novel MRI-guided, magnetically actuated, flexible micro robotic arm technology. This...
Agiliti Launches Essentia™: A Bed to Lower Risk & Boost Mobility
Proprietary safety features support advanced therapies across a wide range of patients and ease the burden on caregivers Agiliti, a leading manufacturer and provider of...
Aegis Launches Dashboard to Track Novel Psychoactive Substances
Aegis Sciences Corporation, a leader in toxicology and healthcare services, is excited to announce the launch of a groundbreaking data visualization dashboard designed to provide...
AdvanCell Partners with Lilly to Advance Targeted Alpha Therapies
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli...
GeneDx Integrates with Epic to Advance Genome Sequencing Adoption
UNC Health to Become the First Health System to Collaborate with GeneDx Through Aura, Epic’s Specialty Diagnostic Suite GeneDx (Nasdaq: WGS), a leader in delivering...
Pfizer and Astellas’ PADCEV® + KEYTRUDA® Shows Long-Term Efficacy
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the Phase 3...
Ingenovis Health Elevates Jan Ross to Chief Information Officer
Ingenovis Health today announced the promotion of Jan Ross to Chief Information Officer, effective immediately. Ross joined the company in March 2023 as Senior Vice...
Citruslabs: UK Wellness Brands Must Prioritise Science-backed Products
– Citruslabs, one of the leading CROs for consumer brands in the US, is expanding its services to the UK, which has a health and wellness...
IDEAYA Appoints Joshua Bleharski as CFO
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced the appointment of Joshua Bleharski, Ph.D....